Table 5.
Results of multinomial logistic regression showing the effect of baseline psychopathological and SRPE characteristics on PE status at follow-up, adjusted for sex and age
| Persistent FP SRPE v. remitted FP SRPE (ref) | Transition to validated PE v. remitted FP SRPE (ref) | Transition to validated PE v. persistent FP SRPE (ref) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Continuous variable | β | 95% int. | p | β | 95% int. | p | β | 95% int. | p |
| General mental functioning | −0.02 | −0.04 to 0.0001 | 0.05 | −0.02 | −0.04 to 0.003 | ns | 0.003 | −0.03 to 0.03 | ns |
| General social functioning | −0.01 | −0.03 to 0.003 | ns | −0.02 | −0.03 to −0.004 | 0.01 | −0.006 | −0.03 to 0.01 | ns |
| General physical functioning | −0.003 | −0.02 to 0.02 | ns | −0.007 | −0.03 to 0.01 | ns | −0.004 | −0.03 to 0.02 | ns |
| General health | −0.01 | −0.03 to 0.01 | ns | −0.03 | −0.04 to −0.01 | 0.004 | −0.02 | −0.04 to 0.006 | ns |
| Onset of SRPE (age in years) | 0.01 | −0.03 to 0.05 | ns | −0.005 | −0.04 to 0.03 | ns | −0.02 | −0.07 to 0.03 | ns |
| Number of SRPE | 0.12 | −0.30 to 0.54 | ns | 0.54 | 0.21–0.86 | 0.001 | 0.41 | −0.08 to 0.90 | ns |
| Frequency of SRPE | 0.35 | −0.11 to 0.80 | ns | 0.44 | −0.03 to 0.91 | 0.07 | 0.09 | −0.53 to 0.71 | ns |
| Distress of SRPE | 0.06 | −0.33 to 0.44 | ns | 0.22 | −0.15 to 0.58 | ns | 0.16 | −0.35 to 0.66 | ns |
| Impact of SRPE | 0.29 | −0.15 to 0.74 | ns | 0.15 | −0.34 to 0.64 | ns | −0.14 | −0.76 to 0.48 | ns |
ns, not significant.